L-Proline, 4-[(3-chloro-7-methoxy-2-quinoxalinyl)oxy]-, methyl ester, (hydrochloride)(1:1),(4R)- CAS: 1361028-94-5
| Product Parameters | |
|---|---|
| Catalog No. | BK6N2V |
| CAS.RN | 1361028-94-5 |
| Molecular Formula | C15H17Cl2N3O4 |
| Molecular Weight | 374.22 g/mol |
| Purity | NLT 98% |
Product Overview
Methyl (2S,4R)-4-((3-chloro-7-methoxyquinazol-2-yl)oxy)pyrrolidine-2-carboxylic acid methyl ester is an important pharmaceutical intermediate widely used in the synthesis of innovative drugs for antitumor and antiviral purposes. This compound possesses a well-defined stereochemical structure and a stable functional group system, making it suitable for drug molecule skeleton construction and the preparation of key intermediates. It can meet the needs of small-scale, pilot-scale, and industrial-scale production in the R&D stage, providing customers with high-purity, high-quality raw material support to aid in new drug development and process optimization.
Applications
- Antitumor drug synthesis
- Preparation of antiviral drug intermediates
- Drug molecular skeleton construction
- Key intermediates in innovative drug development
- Process route optimization and scale-up production
Quality & Supply Capability
English Name: L-Proline, 4-[(3-chloro-7-methoxy-2-quinoxalinyl)oxy]-, methyl ester, (hydrochloride)(1:1),(4R)- Properties: This product is a white to off-white solid containing a quinazoline ring structure and multiple functional groups. It exhibits good chemical stability and reactivity, making it suitable for various organic synthesis reactions. Storage Recommendations: Store in a sealed, light-protected, and dry place, subject to the specific COA/MSDS. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches. Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging. Document Support: COA, MSDS, HPLC, NMR, etc. We provide a full-process supply service from laboratory samples to industrial batch production. We can perform small-scale preparation, pilot-scale amplification, and customized batch production according to customer needs. We also offer flexible supply solutions based on customer requirements for purity, impurity control, packaging specifications, delivery cycle, and quality documentation. We have a professional technical team that can provide customers with comprehensive technical support from laboratory research and development to scale-up production, helping customers achieve process development, route optimization and project transformation.
Why Choose Bioncan
Focused on pharmaceutical intermediates, possessing extensive synthesis experience and technical expertise. Full-scale supply capability, covering samples, gram-level, kilogram-level to commercial-scale batches. Provides complete quality control documentation support, including COA, MSDS, HPLC, NMR, etc. Supports customized needs, adjusting purity, impurity control, and packaging specifications according to customer requirements. Provides supporting process optimization technology to help customers improve synthesis efficiency and product quality. Offers end-to-end support services from laboratory to scale-up, ensuring smooth project progress.
Intermediates of Grazoprevir (potassium salt)
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA52GN | Grazoprevir (potassium salt) API | 1206524-86-8 |
| BK8Q5G | (1R,2S)-1-aMino-N-(cyclopropylsulfonyl)-2-vinylcyclopropanecarboxaMide 4-Methylbenzenesulfonate | 1028252-16-5 |
| BK6N2V | L-Proline, 4-[(3-chloro-7-methoxy-2-quinoxalinyl)oxy]-, methyl ester, (hydrochloride)(1:1),(4R)- | 1361028-94-5 |
| BK90T4 | L-Valine, 3-Methyl-N-[[[(1R,2R)-2-(4-penten-1-yl)cyclopropyl]oxy]carbonyl]- | 1026200-27-0 |
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting
For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 1361028-94-5, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.